6. パーキンソン病 Parkinson disease Clinical trials / Disease details


臨床試験数 : 2,307 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05634876
(ClinicalTrials.gov)
April 202323/11/2022UB-312 in Patients With SynucleinopathiesA Phase 1b Clinical Trial of UB-312 in Patients With SynucleinopathiesMultiple System Atrophy;Parkinson DiseaseBiological: UB-312 Injection;Biological: Placebo InjectionNYU Langone HealthNULLNot yet recruiting40 Years75 YearsAll8Phase 1/Phase 2United States
2NCT04075318
(ClinicalTrials.gov)
August 29, 20195/8/2019Study of UB-312 in Healthy Participants and Parkinson's Disease PatientsA Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UBITh® PD Immunotherapeutic Vaccine (UB-312) in Healthy Participants and Participants With Parkinson's DiseaseParkinson's Disease;ParkinsonismBiological: UB-312;Biological: PlaceboUnited Neuroscience Ltd.Centre for Human Drug Research, Netherlands;Worldwide Clinical Trials;Vaxxinity, Inc.Active, not recruiting40 Years85 YearsAll70Phase 1Netherlands